Schedule 13G ownership disclosure
Timber Pharmaceuticals, Inc.
Security class unavailable · CUSIP: 887080109
Event date: 2020-05-18
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,126,325
- Percent of class
- 9.4900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000902664-20-002221
- Form type
- SC 13G
- Filer
- Empery Asset Management, LP
- CIK
- CIK 1469336
- Filed
- May 27, 2020
- Reporting period
- May 18, 2020
- Description
- Schedule 13G beneficial ownership